Transcenta announces the appointment of Daniel Weng as CFO
FutureCFO Editors
January 18, 2022
Hong Kong-listed clinical stage biopharmaceutical firm Transcenta Holding Limited announces the appointment of Daniel Weng as the company’s CFO. As a member